Literature DB >> 35527417

[Expression of miR-106b-5p in children with primary immune thrombocytopenia and its correlation with T cells].

Wen-Fang Wang1, Xu-Song Wang1, San-Yang Tan1, Lan-Lan Zhong, Jiang Chen.   

Abstract

OBJECTIVES: To study the expression level of plasma miR-106b-5p in primary immune thrombocytopenia (ITP) and its correlation with the levels of T helper 17 cell (Th17) and regulatory T cell (Treg) and the Th17/Treg ratio.
METHODS: A total of 79 children with ITP (ITP group) and 40 healthy children (control group) were selected as subjects. According to the treatment response, the 79 children with ITP were divided into three groups: complete response (n=40), partial response (n=18), and non-response (n=21). Quantitative real-time PCR was used to measure the expression level of miR-106b-5p. Flow cytometry was used to measure the frequencies of Th17 and Treg, and the Th17/Treg ratio was calculated. The correlation of the expression level of plasma miR-106b-5p with the frequencies of Th17 and Treg and the Th17/Treg ratio was analyzed.
RESULTS: Compared with the control group, the ITP group had significantly higher levels of miR-106b-5p, Th17, and Th17/Treg ratio (P<0.05) and a significantly lower level of Treg (P<0.05). After treatment, the ITP group had significant reductions in the levels of miR-106b-5p, Th17, and Th17/Treg ratio (P<0.05) and a significant increase in the level of Treg (P<0.05). Compared with the partial response and non-response groups, the complete response group had significantly lower levels of miR-106b-5p, Th17, and Th17/Treg ratio (P<0.05) and a significantly higher level of Treg (P<0.05). The correlation analysis showed that in the children with ITP, the expression level of plasma miR-106b-5p was positively correlated with the Th17 level and the Th17/Treg ratio (r=0.730 and 0.816 respectively; P<0.001) and was negatively correlated with the Treg level (r=-0.774, P<0.001).
CONCLUSIONS: A higher expression level of miR-106b-5p and Th17/Treg imbalance may be observed in children with ITP. The measurement of miR-106b-5p, Th17, Treg, and Th17/Treg ratio during treatment may be useful to the evaluation of treatment outcome in children with ITP.

Entities:  

Keywords:  Child; Primary immune thrombocytopenia; Regulatory T cell; T helper 17 cell; miR-106b-5p

Mesh:

Substances:

Year:  2022        PMID: 35527417      PMCID: PMC9044986          DOI: 10.7499/j.issn.1008-8830.2110139

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  17 in total

1.  The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients.

Authors:  Luya Cheng; Chanjuan Liu; Feng Li; Boting Wu; Zhihui Min; Pu Chen; Yanxia Zhan; Yang Ke; Fanli Hua; Ling Yuan; Lihua Sun; Hao Chen; Lili Ji; Yunfeng Cheng
Journal:  Thromb Res       Date:  2019-07-02       Impact factor: 3.944

2.  Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.

Authors:  Shih-Chung Wang; Kuender D Yang; Ching-Yuang Lin; Alex Y Huang; Chien-Chou Hsiao; Ming-Tsan Lin; Yi-Giien Tsai
Journal:  Pediatr Blood Cancer       Date:  2019-11-17       Impact factor: 3.167

3.  MicroRNAs as the Important Regulators of T Helper 17 Cells: A Narrative Review.

Authors:  Mahdi Atabaki; Zhaleh Shariati-Sarabi; Mehdi Barati; Jalil Tavakkol-Afshari; Mojgan Mohammadi
Journal:  Iran J Allergy Asthma Immunol       Date:  2020-12-19       Impact factor: 1.464

4.  Dysregulated expression of miRNAs in immune thrombocytopenia.

Authors:  Abdollah Jafarzadeh; Havva Marzban; Maryam Nemati; Sara Jafarzadeh; Maryam Mahjoubin-Tehran; Michael R Hamblin; Hamed Mirzaei; Hamid Reza Mirzaei
Journal:  Epigenomics       Date:  2021-09-09       Impact factor: 4.778

5.  Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center.

Authors:  Hao Gu; Zhenping Chen; Xiaodong Shi; Hong Cui; Xuanguang Qin; Huimin Hu; Jingyao Ma; Lingling Fu; Jie Ma; Tianyou Wang; Runhui Wu
Journal:  Eur J Pediatr       Date:  2021-05-27       Impact factor: 3.183

6.  MicroRNA profile in immune response of alveolar and cystic echinococcosis patients.

Authors:  Fadime Eroglu; Mehmet Dokur; Yüksel Ulu
Journal:  Parasite Immunol       Date:  2021-05-07       Impact factor: 2.280

7.  Bone marrow mesenchymal stem cell-derived exosomes induce the Th17/Treg imbalance in immune thrombocytopenia through miR-146a-5p/IRAK1 axis.

Authors:  Yue He; Dexiang Ji; Wei Lu; Fei Li; Xianbao Huang; Ruibin Huang; Guoan Chen
Journal:  Hum Cell       Date:  2021-05-30       Impact factor: 4.174

Review 8.  Immune Thrombocytopenia in Children: Consensus and Controversies.

Authors:  Gurpreet Singh; Deepak Bansal; Nicola A M Wright
Journal:  Indian J Pediatr       Date:  2020-01-11       Impact factor: 5.319

9.  Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.

Authors:  Yunqi Sun; Yu Hou; Guiyue Meng; Panpan Han; Yajing Zhao; Haoyi Wang; Miao Xu; Yawen Wang; Jihua Qiu; Jun Peng; Linlin Shao; Lu Sun; Ming Hou
Journal:  Br J Haematol       Date:  2021-08-01       Impact factor: 6.998

Review 10.  Romiplostim in children with newly diagnosed or persistent primary immune thrombocytopenia.

Authors:  John D Grainger; Thomas Kühne; Jane Hippenmeyer; Nichola Cooper
Journal:  Ann Hematol       Date:  2021-07-26       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.